BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1487426)

  • 1. Hemoglobinopathies in Yugoslavia: an update.
    Efremov GD
    Hemoglobin; 1992; 16(6):531-44. PubMed ID: 1487426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalassemias and other hemoglobinopathies in the Republic of Macedonia.
    Efremov GD
    Hemoglobin; 2007; 31(1):1-15. PubMed ID: 17365000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-, delta beta-thalassemia and Hb lepore among Yugoslav, Bulgarian, Turkish and Albanian.
    Efremov GD
    Haematologica; 1990; 75 Suppl 5():31-41. PubMed ID: 2086380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular-genetic characteristics of alpha, beta and delta beta-thalassemias in 139 heterozygotes in 56 unrelated Czech and Slovak families (Priority description of 3 beta-thalassemia mutations, an extensive alpha-thalassemia 2 (18+ kb) deletion and a Swiss-type nondeletion hereditary persistence of hemoglobin F)].
    Indrák K; Divoký V; Brabec V; Indráková J; Svobodová M; Huisman TH
    Vnitr Lek; 1993 Oct; 39(10):969-78. PubMed ID: 7694425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobinopathies in the Çukurova Region and Neighboring Provinces.
    Yuzbasioglu Ariyurek S; Yildiz SM; Yalin AE; Guzelgul F; Aksoy K
    Hemoglobin; 2016 Jun; 40(3):168-72. PubMed ID: 26984585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
    Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM
    Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Iranian thalassemic families for the most common deletions of the beta-globin gene cluster.
    Esteghamat F; Imanian H; Azarkeivan A; Pourfarzad F; Almadani N; Najmabadi H
    Hemoglobin; 2007; 31(4):463-9. PubMed ID: 17994380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis of beta-thalassemia and other hemoglobinopathies in Bulgaria: an update.
    Petkov GH; Efremov GD
    Hemoglobin; 2007; 31(2):225-32. PubMed ID: 17486505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Epidemiology of Hemoglobinopathies in Cambodia.
    Munkongdee T; Tanakulmas J; Butthep P; Winichagoon P; Main B; Yiannakis M; George J; Devenish R; Fucharoen S; Svasti S
    Hemoglobin; 2016 Jun; 40(3):163-7. PubMed ID: 27117566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
    Ding ZY; Shen GS; Zhang S; He PY
    Hemoglobin; 2016 Sep; 40(5):304-309. PubMed ID: 27615034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobinopathies among the Gond tribal groups of central India; interaction of alpha- and beta-thalassemia with beta chain variants.
    Gupta RB; Tiwary RS; Pande PL; Kutlar F; Oner C; Oner R; Huisman TH
    Hemoglobin; 1991; 15(5):441-58. PubMed ID: 1802886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and geographical heterogeneity of hemoglobinopathy mutations in Azerbaijanian populations.
    Aliyeva G; Asadov C; Mammadova T; Gafarova S; Guliyeva Y; Abdulalimov E
    Ann Hum Genet; 2020 May; 84(3):249-258. PubMed ID: 31755088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].
    Fattoum S
    Tunis Med; 2006 Nov; 84(11):687-96. PubMed ID: 17294892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Globin mRNA in beta-thalassemia heterozygotes with different beta-thalassemia alleles and in heterozygotes for hereditary persistence of fetal hemoglobin.
    Smetanina NS; Adekile AD; Huisman TH
    Acta Haematol; 1996; 96(3):162-9. PubMed ID: 8876614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of two different disorders in the beta-globin gene cluster associated with an increased hemoglobin F production: a novel deletion type of (G) gamma + ((A) gamma delta beta)(0)-thalassemia and a delta(0)-hereditary persistence of fetal hemoglobin determinant.
    Losekoot M; Fodde R; Gerritsen EJ; van de Kuit I; Schreuder A; Giordano PC; Vossen JM; Bernini LF
    Blood; 1991 Feb; 77(4):861-7. PubMed ID: 1704267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-thalassemia in Yugoslavia.
    Dimovski A; Efremov DG; Jankovic L; Juricic D; Zisovski N; Stojanovski N; Nikolov N; Petkov GT; Reese AL; Stoming TA
    Hemoglobin; 1990; 14(1):15-24. PubMed ID: 2200761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of β-thalassemia in the United Arab Emirates.
    Baysal E
    Hemoglobin; 2011; 35(5-6):581-8. PubMed ID: 22074124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization and phenotypical study of β-thalassemia in Tucumán, Argentina.
    Lazarte SS; Mónaco ME; Haro AC; Jiménez CL; Ledesma Achem ME; Issé BA
    Hemoglobin; 2014; 38(6):394-401. PubMed ID: 25347257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hb H disease with various β hemoglobinopathies: molecular, hematological and diagnostic aspects.
    Fucharoen S; Fucharoen G
    Hemoglobin; 2012; 36(1):18-24. PubMed ID: 22145566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of deletions causing delta beta thalassemia and hereditary persistence of fetal hemoglobin by enzymatic amplification.
    Craig JE; Barnetson RA; Prior J; Raven JL; Thein SL
    Blood; 1994 Mar; 83(6):1673-82. PubMed ID: 7510147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.